⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27578538 | 0.98 | — | — | |
| SCHEMBL9115301 | 0.85 | GABRR1 (0.37) | — | |
| SCHEMBL4736995 | 0.85 | ALOX15 (0.30) | — | |
| SCHEMBL11493168 | 0.83 | GSR (0.42) | — | |
| SCHEMBL7780077 | 0.83 | GRIK1 (0.43) | — | |
| SCHEMBL9701317 | 0.83 | GRIK1 (0.45) | — | |
| SCHEMBL17222477 | 0.83 | GRIK1 (0.45) | — | |
| SCHEMBL8508905 | 0.82 | GSR (0.46) | — | |
| SCHEMBL8508705 | 0.82 | GSR (0.46) | — | |
| SCHEMBL9021115 | 0.81 | TSHR (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4725279-A | BURN DRESSINGS; POLYMERIC SUBSTRATE TREATED WITH ACTIVATED AMINES COUPLED TO BIOLOGICAL MATERIAL | STERLING DRUG INC. (US) | 1988-02-16 | — | — | US | claimed |
| CN-115491418-A | Second-generation sequencing panel of target genes with congenital incomplete lens dislocation and sequencing method | 复旦大学附属眼耳鼻喉科医院 | 2022-12-20 | — | — | CN | disclosed |
| US-20180369391-A1 | HYDROGEL FOAMS AND METHODS OF MAKING AND USING THE SAME | Lineage Cell Therapeutics, Inc. | 2018-12-27 | — | — | US | disclosed |
| US-10035840-B2 | Targeted coagulation factors and method of using the same | BAYER HEALTHCARE LLC (US) | 2018-07-31 | — | — | US | disclosed |
| US-20170312392-A1 | Tissue Engineering Methods and Compositions | CYTEX THERAPEUTICS INC (US) | 2017-11-02 | — | — | US | disclosed |
| US-20170051042-A1 | TARGETED COAGULATION FACTORS AND METHOD OF USING THE SAME | BAYER HEALTHCARE LLC | 2017-02-23 | — | — | US | disclosed |
| US-9422362-B2 | Targeted coagulation factors and method of using the same | BAYER HEALTHCARE LLC (US) | 2016-08-23 | — | — | US | disclosed |
| US-9125735-B2 | Method of correcting vision using corneal onlays | FORSIGHT LABS, LLC (US) | 2015-09-08 | — | — | US | disclosed |
| CN-103221443-B | Resol, preparation method, for the sizing composition of mineral fibre and the product of acquisition | SAINT-GOBAIN ISOVER (FR) | 2015-08-12 | — | — | CN | disclosed |
| US-20140363465-A1 | MYCOBACTERIAL VACCINE VECTORS AND METHODS OF USING THE SAME | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2014-12-11 | — | — | US | disclosed |
| EP-0971686-B1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A DERIVATIVE OF METHYLATED SILANOL AND A DERIVATIVE OF HYDROLYSED PLANT PROTEIN | BEIERSDORF AG (DE) | 2004-11-03 | — | — | EP | disclosed |
| US-20040023048-A1 | Enhanced bonding layers on native oxide surfaces | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-02-05 | — | — | US | disclosed |
| US-20040001959-A1 | Enhanced bonding layers on titanium materials | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-01-01 | — | — | US | disclosed |
| US-6660915-B2 | Mutated protein; storage stable malt, beer and brewed beverages | HEINEKEN TECHNICAL SERVICES, B.V. (NL) | 2003-12-09 | — | — | US | disclosed |
| US-20030167544-A1 | Low lipoxygenase 1 barley | BRASSERIES KRONENBOURG SOCIETE EN COMMANDITE PAR ACTIONS (FR) | 2003-09-04 | — | — | US | disclosed |
| WO-2002053720-A1 | LOW-LIPOXYGENASE 1 BARLEY | CARLSBERG RESEARCH LABORATORY (US) | 2002-07-11 | — | — | WO | disclosed |
| US-20020025303-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A DERIVATIVE OF METHYLATED SILANOL AND A DERIVATIVE OF HYDROLYSED PLANT PROTEIN | BOOTS COMPANY, THE PLC (GB) | 2002-02-28 | — | — | US | disclosed |
| EP-0971686-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A DERIVATIVE OF METHYLATED SILANOL AND A DERIVATIVE OF HYDROLYSED PLANT PROTEIN | The Boots Company PLC (GB) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998044904-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A DERIVATIVE OF METHYLATED SILANOL AND A DERIVATIVE OF HYDROLYSED PLANT PROTEIN | THE BOOTS COMPANY PLC (GB) | 1998-10-15 | — | — | WO | disclosed |
| WO-1991019505-A1 | MODIFIED HUMAN HEMOGLOBIN, BLOOD SUBSTITUTES CONTAINING THE SAME, AND VECTORS FOR EXPRESSING THE MODIFIED HEMOGLOBIN | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-12-26 | — | — | WO | disclosed |